Systematic Review of Emerging Models of Cancer Care: Implications for the Health Industry

Journal Title: Journal of Integrative Oncology - Year 2017, Vol 6, Issue 4

Abstract

In selected patients diagnosed with Breast Cancer (BC), adjuvant chemotherapy might reduce local and systemic recurrence risk, as well as cancer death rate. The combination of Docetaxel and Cyclophosphamide (TC) is a wellrecognized effective adjuvant chemotherapy regimen. Nonetheless, a considerable high rate of febrile neutropenia (FN) is associated with this regimen. We sought to investigate hematologic toxicity associated with adjuvant TC in a non-selected, “real world” cohort of BC patients. Methods: We reviewed the electronic medical records of patients who presented to the Oncology Center from Hospital Sírio-Libanês (HSL) and Instituto do Câncer do Estado de Sao Paulo (ICESP). Patients included in the analysis received adjuvant chemotherapy with TC regimen after definitive breast surgery. Results: 95 patients with were included in our analysis. Median age was 55.5 years. All patients had a good performance status (either ECOG 0 or 1), and the great majority had no comorbidities. Most patients received 4 cycles of chemotherapy (80%). Data on granulocyte colony stimulating factor (G-CSF) administration was available in 85 patients from our cohort. G-CSF was used as primary prophylaxis in 31 patients, and as secondary prophylaxis in 13 patients, following a prior episode of febrile neutropenia. Overall, fifteen women (15.8%) had a documented FN episode. Among women who received G-CSF as primary prophylaxis, the rate of FN was 6.45% (2 patients). In contrast, among patients who did not receive primary prophylaxis with G-CSF, FN rate was considerably higher, namely 24.07% (13 patients). Patients who received primary prophylaxis with G-CSF had a statistically significant lower risk of experiencing a FN episode (p=0.049). Conclusion: Febrile Neutropenia rate in this group of non-selected BC patients was higher than previous reported on randomized controlled trials that evaluated adjuvant TC regimen in the same dosing and schedule as used in our cohort. Primary prophylaxis with G-CSF was associated with a statistically significant lower risk of FN and should be considered in the management of patients who receive this chemotherapy combination.

Authors and Affiliations

Bita Kash, Molly McKahan, Sarah Mack, Upali Nanda

Keywords

Related Articles

Analysis of Set-up Parameters in Head and Neck Patients at the Charlotte Maxeke Johannesburg Academic Hospital (A Review of Current Clinical Practice)

This study aimed to collect and analyze the recorded daily setup parameters of the bed as incidentally captured on an integrated record and verify system. This was done on some radical head and neck patients treated from...

A Red Skin Nodule

A 78-year-old woman presented with a 2-month-history of a cutaneous red nodule on her left leg (Figure 1). Differential diagnosis of nodular red lesions includes dermal nevus, pyogenic granuloma, angioma, amelanotic mela...

Homeopathy: Curative, Concurrent and Supportive Cancer Treatment Potential

Background: Homeopathy is used by 12 to 24% of European cancer patients, representing 40.4% of patients at European integrative cancer centers. In 2011, a Swiss literature review on homeopathy led to homeopathic treatmen...

Nurses’ Knowledge and Perceptions of Advance Care Planning, an Ethical Responsibility

Discussions around advance care planning (ACP) do not mean making decisions about what to do at the end of life, but how to cope with disease and treatment. Studies suggest that HPs and patients are ambivalent when talki...

The Chernobyl and It’s Long Term Consequence: Clinical Cases of Leukemia

The Chernobyl accident that occurred 30 years ago was one of the worst nuclear disasters ever. Although it’s effects have been the subject of several articles, the role of its repercussions in the etiology of hematologic...

Download PDF file
  • EP ID EP348635
  • DOI 10.4172/2329-6771.1000196
  • Views 59
  • Downloads 0

How To Cite

Bita Kash, Molly McKahan, Sarah Mack, Upali Nanda (2017). Systematic Review of Emerging Models of Cancer Care: Implications for the Health Industry. Journal of Integrative Oncology, 6(4), 1-8. https://europub.co.uk/articles/-A-348635